Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression
Kie Kyon Huang,Haoran Ma,Roxanne Hui Heng Chong,Tomoyuki Uchihara,Benedict Shi Xiang Lian,Feng Zhu,Taotao Sheng,Supriya Srivastava,Su Ting Tay,Raghav Sundar,Angie Lay Keng Tan,Xuewen Ong,Minghui Lee,Shamaine Wei Ting Ho,Tom Lesluyes,Hassan Ashktorab,Duane Smoot,Peter Van Loo,Joy Shijia Chua,Kalpana Ramnarayanan,Louis Ho Shing Lau,Takuji Gotoda,Hyun Soo Kim,Tiing Leong Ang,Christopher Khor,Jonathan Wei Jie Lee,Stephen Kin Kwok Tsao,Wei Lyn Yang,Ming Teh,Hyunsoo Chung,Jimmy Bok Yan So,Khay Guan Yeoh,Patrick Tan,Singapore Gastric Cancer Consortium
DOI: https://doi.org/10.1016/j.ccell.2023.10.004
IF: 50.3
2023-12-11
Cancer Cell
Abstract:Intestinal metaplasia (IM) is a pre-malignant condition of the gastric mucosa associated with increased gastric cancer (GC) risk. Analyzing 1,256 gastric samples (1,152 IMs) across 692 subjects from a prospective 10-year study, we identify 26 IM driver genes in diverse pathways including chromatin regulation (ARID1A) and intestinal homeostasis (SOX9). Single-cell and spatial profiles highlight changes in tissue ecology and IM lineage heterogeneity, including an intestinal stem-cell dominant cellular compartment linked to early malignancy. Expanded transcriptome profiling reveals expression-based molecular subtypes of IM associated with incomplete histology, antral/intestinal cell types, ARID1A mutations, inflammation, and microbial communities normally associated with the healthy oral tract. We demonstrate that combined clinical-genomic models outperform clinical-only models in predicting IMs likely to transform to GC. By highlighting strategies for accurately identifying IM patients at high GC risk and a role for microbial dysbiosis in IM progression, our results raise opportunities for GC precision prevention and interception.